Introduction:Basic information about CAS 138398-61-5|Amylin (8-37) (mouse, rat), including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Amylin (8-37) (mouse, rat) |
|---|
| CAS Number | 138398-61-5 | Molecular Weight | 3200.56000 |
|---|
| Density | / | Boiling Point | / |
|---|
| Molecular Formula | C140H227N43O43 | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
| Name | amylin (8-37) (rat) |
|---|
| Synonym | More Synonyms |
|---|
Amylin (8-37) (mouse, rat) BiologicalActivity
| Description | Amylin (8-37), rat is a truncated analog of native Amylin that selectively inhibits insulin-related glucose uptake and glycogen deposition in muscle tissue. Amylin (8-37), rat is a weak amylin receptor (AMY) antagonist. |
|---|
| Related Catalog | Signaling Pathways >>Others >>OthersResearch Areas >>Metabolic DiseasePeptides |
|---|
| Target | Amylin receptor (AMY)[1] |
|---|
| In Vitro | Amylin (8-37), rat (Rat amylin-(8-37)) enhances insulin action and alters lipid metabolism in normal and insulin-resistant rats. Amylin (8-37) reduces plasma insulin (P<0.001) and enhances several measures of whole body and muscle insulin sensitivity (P<0.05) in both saline- and hGH-infused rats. Amylin-(8-37) corrects hGH-induced liver insulin resistance, increases basal plasma triglycerides and lowers plasma nonesterified fatty acids in both groups, and reduces muscle triglyceride and total long-chain acyl-CoA content in saline-treated rats (P<0.05). In isolated soleus muscle, Amylin (8-37) blocks amylin-induced inhibition of glycogen synthesis but has no effect in the absence of amylin. Thus 1) hyperamylinemia accompanies insulin resistance induced by hGH infusion; 2) Amylin (8-37) increases whole body and muscle insulin sensitivity and consistently reduces basal insulin levels in normal and hGH-induced insulin resistant rats; and 3) Amylin (8-37) elicits a significant alteration of in vivo lipid metabolism[2]. |
|---|
| References | [1]. Bower RL, et al. Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development. Br J Pharmacol. 2016 Jun;173(12):1883-98. [2]. Hettiarachchi M, et al. Rat amylin-(8-37) enhances insulin action and alters lipid metabolism in normal and insulin-resistant rats. Am J Physiol. 1997 Nov;273(5 Pt 1):E859-67. |
|---|
Chemical & Physical Properties
| Molecular Formula | C140H227N43O43 |
|---|
| Molecular Weight | 3200.56000 |
|---|
| Exact Mass | 3198.69000 |
|---|
| PSA | 1410.59000 |
|---|
| InChIKey | KXIRMGRGEHRNNC-ANJGTFPLSA-N |
|---|
| SMILES | CC(C)CC(NC(=O)C(CC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(N)=O)NC(=O)C(NC(=O)C(C)N)C(C)O)C(C)C)C(=O)NCC(=O)N1CCCC1C(=O)NC(C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NCC(=O)NC(CO)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(Cc1ccc(O)cc1)C(N)=O)C(C)O)C(C)C)C(C)O)C(C)C |
|---|
Synonyms
| Amylin (8-37) (mouse,rat) |
| ATQRLANFLVRSSNNLGPVLPPTNVGSNTY-NH2 |
| H-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 |
| diabetes associated peptide amide*fragment 8-37 R |
| Amylin (8-37), rat |